最近关于瘤特异响应性水凝的研究进展
Xuan-Yi Zhou1,2, Chen-Kai Wang3,2, Ze-Fan Shen3,2
1The Second School of Clinical Medicine, Hangzhou Normal University, Hangzhou, Zhejiang, China. clinic@zju.edu.cn.
Journal of materials chemistry. B
|July 1, 2024
概括
响应瘤的水凝通过专门针对癌症部位,提供了改进的抗癌疗法. 本综述详细介绍了凝,分解或在瘤内发生反应的水凝,提高了疗效并减少了副作用.
科学领域:
- 生物材料科学 生物材料科学
- 药物运输 药物运输 药物运输
- 在瘤学瘤学.
背景情况:
- 注射用水凝通常在注射后立即凝,阻碍向药物输送.
- 这种快速凝限制了水凝在抗癌治疗中的有效性,因为瘤积累不良.
- 开发针对特定瘤的刺激反应性水凝对于改善癌症治疗结果至关重要.
研究的目的:
- 审查瘤反应性水凝的开发和应用,以加强抗癌治疗.
- 根据它们与瘤微环境的特定相互作用,对瘤有反应的水凝进行分类.
- 讨论这些先进的水凝系统的组成,机制和治疗潜力.
主要方法:
- 对刺激反应和瘤特异性水凝的现有文献的审查.
- 水凝分为三个主要类型:瘤凝,瘤分解和瘤反应.
- 对瘤特异性反应背后的机制及其在临床前和临床环境中的应用进行全面分析.
主要成果:
- 确定了三种不同的策略来创建瘤响应的水凝:特定位点的凝,特定位点的分解和特定瘤的反应.
- 详细说明了每个水凝类型的组成和响应机制.
- 突出了改善的瘤向性,治疗效果和减少与这些水凝相关的全身毒性.
结论:
- 响应瘤的水凝代表了向癌症治疗的重大进步.
- 这些水凝通过利用瘤特异性刺激来克服即时凝系统的局限性.
- 进一步的开发有望为更有效,更安全的抗癌治疗提供希望.
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...


